is compound pharmacy semaglutide safe FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products How to Tell if Your

Payers are talking about this because its impacting everyone

Vial of unapproved peptide retatrutide had double the strength indicated on label Sat 27 Jun 2026 at 4:41am In short: Test results on an unapproved peptide have revealed double the concentration listed on the label, prompting warnings from health professionals about "enormous" overdose risks

Researchers from the University of Southern California and the University of California San Diego evaluated a large, nationally representative electronic health records database to determine the incidence of primary open-angle glaucoma (POAG), ocular hypertension (OHT) and first-line glaucoma interventions in patients with type 2 diabetes mellitus (DM) treated with tirzepatide vs

A 2025 Cell Metabolism analysis noted that lean mass loss on GLP-1 receptor agonists has raised genuine questions about the long-term metabolic implications particularly for people already experiencing age-related muscle decline

It contains the active ingredient, retatrutide, and is being developed by the same manufacturer as Mounjaro, Eli Lilly, for the management of obesity and type 2 diabetes

What I saw in the trial data is that participants in Phase 2 received the drug at no cost and had close medical monitoring throughout